← Back to Search

Speech Tasks for Speech Perception

N/A
Waitlist Available
Led By Edward F Chang, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure
Awards & highlights

Study Summary

This trial is investigating how the brain extracts linguistic elements from speech sounds in order to better understand and treat human language disorders.

Who is the study for?
This trial is for individuals at UCSF with epilepsy or brain tumors who are undergoing surgical electrode implantation. They must have electrodes in at least two key brain areas and be able to perform study tasks. Those unable to consent, with significant cerebral lesions, or cognitive deficits that prevent task completion cannot participate.Check my eligibility
What is being tested?
The study investigates how the superior temporal gyrus of the brain processes speech sounds. Participants will perform speech tasks while their brain activity is monitored to understand how we perceive words and continuous speech, aiming to improve language disorder treatments.See study design
What are the potential side effects?
Since this trial involves non-invasive speech tasks without drugs or medical procedures beyond those already required for participants' clinical care, there are no direct side effects from the interventions being studied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and during procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants with Electrocorticography (ECoG) Signals for Neural Activity Identified During Intraoperative Procedure or Inpatient Hospitalization

Trial Design

1Treatment groups
Experimental Treatment
Group I: Electrocorticography (ECoG) recording during Speech TasksExperimental Treatment1 Intervention
Participants listened to 25-minute Speech Tasks while ECoG signals for neural activity was recorded during their intraoperative procedure or inpatient hospitalization at the University of California, San Francisco (UCSF).

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,500 Previous Clinical Trials
15,236,411 Total Patients Enrolled
2 Trials studying Speech
82 Patients Enrolled for Speech
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
327 Previous Clinical Trials
178,155 Total Patients Enrolled
11 Trials studying Speech
1,331 Patients Enrolled for Speech
University of California, BerkeleyOTHER
180 Previous Clinical Trials
721,126 Total Patients Enrolled
1 Trials studying Speech
52 Patients Enrolled for Speech

Media Library

Speech Tasks Clinical Trial Eligibility Overview. Trial Name: NCT05435859 — N/A
Speech Research Study Groups: Electrocorticography (ECoG) recording during Speech Tasks
Speech Clinical Trial 2023: Speech Tasks Highlights & Side Effects. Trial Name: NCT05435859 — N/A
Speech Tasks 2023 Treatment Timeline for Medical Study. Trial Name: NCT05435859 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts underway for this investigative trial?

"Clinicaltrials.gov has confirmed that this study's recruitment window closed on June 22nd 2022; thus, it is not actively seeking participants. Fortunately, 648 other trials are currently enrolling patients."

Answered by AI

Am I eligible to be a participant in this scientific research?

"To be considered for this clinical trial, aspiring participants must exhibit the symptom of aura and remain within 18 to 70 years old. This study is in search of a total of 60 qualified candidates."

Answered by AI

Can persons aged 35 or above participate in this research?

"As per the trial's prerequisites, individuals aged 18-70 are eligible for enrolment."

Answered by AI
~16 spots leftby Jul 2027